{"id":"W4386726566","doi":"10.1177/10600280231198925","title":"Sparsentan: A First-in-Class Dual Endothelin and Angiotensin II Receptor Antagonist","year":2023,"lang":"en","type":"review","venue":"Annals of Pharmacotherapy","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Fraser Health","funders":"","keywords":"Endothelin receptor antagonist; Endothelin receptor; Angiotensin II; Dual (grammatical number); Antagonist; Pharmacology; Receptor antagonist; Angiotensin II receptor antagonist; Angiotensin receptor; Medicine; Internal medicine; Endocrinology; Receptor; Philosophy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001268044,0.0003510072,0.001305126,0.001977776,0.0001589531,0.0009303503,0.0006249133,0.0006393669,0.01004302],"category_scores_gemma":[0.002350206,0.0001237358,0.0008798421,0.001753422,0.0002396277,0.0009184806,0.000468462,0.0006910767,0.001215611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004972545,"about_ca_system_score_gemma":0.001493664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00039758,"about_ca_topic_score_gemma":0.001685755,"domain_scores_codex":[0.9992892,0.0002280119,0.000228557,0.00007318823,0.0001548506,0.0000262101],"domain_scores_gemma":[0.9982024,0.000881587,0.0007104002,0.0000220732,0.0001167249,0.00006675333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003573699,0.0002759176,0.0007456946,0.2119176,0.001001816,0.0004729765,0.0001163387,0.0004307342,0.002932242,0.0023769,0.03627494,0.739881],"study_design_scores_gemma":[0.006881296,0.004690594,0.01403447,0.2298183,0.007974081,0.004311851,0.0002767354,0.001073362,0.003103581,0.003069797,0.7246487,0.0001172455],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00933099,0.9664431,0.001427322,0.00424656,0.0006435709,0.000947354,0.003808559,0.00009863843,0.01305396],"genre_scores_gemma":[0.04863857,0.9312186,0.006303241,0.004649121,0.001097318,0.001101959,0.002991339,0.00002766395,0.003972177],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01004302,"threshold_uncertainty_score":0.03359729,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1302585749749818,"score_gpt":0.4200671035542233,"score_spread":0.2898085285792416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}